Target intelligence / Profile preview

NLR family pyrin domain containing 3 (NLRP3) inflammasome (NLRP3)

Target
NLRP3
Molecular classification
Pattern recognition receptor, NLR family, Inflammasome, Cytosolic sensor
01

Overview

The NLR family pyrin domain containing 3 (NLRP3) inflammasome is a multi-protein complex that serves as a critical component of the innate immune system (UniProt Q96P20). It consists of the NLRP3 sensor, the ASC adapter, and pro-caspase-1. Upon activation by various stimuli—including crystalline substances like aluminum phosphate, a common vaccine adjuvant—the complex assembles to trigger the maturation and secretion of pro-inflammatory cytokines IL-1β and IL-18, as well as pyroptotic cell death (Eisenbarth et al., Nature 2008). Dysregulation of NLRP3 is linked to numerous inflammatory conditions, such as cryopyrin-associated periodic syndromes (CAPS), gout, and metabolic disorders (Mangan et al., Nature Reviews Drug Discovery 2018). Therapeutic strategies focus on inhibiting NLRP3 assembly or activity to mitigate chronic inflammation. Aluminum phosphate's role as an adjuvant is largely attributed to its ability to activate this specific inflammasome pathway, thereby enhancing the immune response to co-administered antigens (Kool et al., Journal of Experimental Medicine 2008).

Other names
CryopyrinCIAS1PYPAF1NALP3Caspase recruitment domain-containing protein 7
02

Mechanism of action

NLRP3 inhibitors typically bind to the NACHT domain of the NLRP3 protein, interfering with its ATPase activity and preventing the conformational change required for oligomerization and ASC recruitment (Mangan et al., Nature Reviews Drug Discovery 2018). Aluminum phosphate acts as an activator by inducing lysosomal rupture upon phagocytosis, leading to the release of cathepsins and subsequent NLRP3 assembly (Eisenbarth et al., Nature 2008).

03

Biological functions

Immune responseCytokine processingInflammationPyroptosisProteolysis
04

Disease associations

Cryopyrin-associated periodic syndrome (CAPS)GoutType 2 diabetesAlzheimer's diseaseAtherosclerosisNonalcoholic steatohepatitis (NASH)
05

Safety considerations

Increased risk of opportunistic infectionsPotential for impaired wound healingRisk of immunosuppression
06

Interacting drugs

Dapansutrile

6 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1β)Interleukin-18 (IL-18)Caspase-1C-reactive protein (CRP)

Beyond the preview

Go deeper on NLR family pyrin domain containing 3 (NLRP3) inflammasome (NLRP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NLR family pyrin domain containing 3 (NLRP3) inflammasome (NLRP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call